메뉴 건너뛰기




Volumn 30, Issue 11, 2010, Pages 4695-4699

A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer

Author keywords

Adjuvant chemotherapy; Carboplatin; Gemcitabine; NSCLC; Paclitaxel; Surgical resection; Treatment compliance

Indexed keywords

CARBOPLATIN; GEMCITABINE; PACLITAXEL;

EID: 78650234006     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (21)

References (19)
  • 6
    • 5444235920 scopus 로고    scopus 로고
    • Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
    • DOI 10.1200/JCO.2004.02.109
    • Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M and Tanimoto M: Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small cell lung cancer. J Clin Oncol 22: 3852-3859, 2004. (Pubitemid 41079865)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.19 , pp. 3852-3859
    • Hotta, K.1    Matsuo, K.2    Ueoka, H.3    Kiura, K.4    Tabata, M.5    Tanimoto, M.6
  • 7
    • 77955786290 scopus 로고    scopus 로고
    • Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer
    • Sugaya M, Uramoto H, Uchiyama A, Nagashima A, Nakanishi R, Sakata H, Nakanishi K, Hanagiri T and Yasumoto K: Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer. Anticancer Res 30: 3039-3044, 2010.
    • (2010) Anticancer Res , vol.30 , pp. 3039-3044
    • Sugaya, M.1    Uramoto, H.2    Uchiyama, A.3    Nagashima, A.4    Nakanishi, R.5    Sakata, H.6    Nakanishi, K.7    Hanagiri, T.8    Yasumoto, K.9
  • 10
    • 33746322562 scopus 로고    scopus 로고
    • Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104
    • DOI 10.1002/cncr.22024
    • Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, Matsui K, Kashii T, Takada M, Nakanishi Y, Kato T and Fukuoka M: Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104. Cancer 107: 599-605, 2006. (Pubitemid 44107221)
    • (2006) Cancer , vol.107 , Issue.3 , pp. 599-605
    • Yamamoto, N.1    Nakagawa, K.2    Uejima, H.3    Sugiura, T.4    Takada, Y.5    Negoro, S.-I.6    Matsui, K.7    Kashii, T.8    Takada, M.9    Nakanishi, Y.10    Kato, T.11    Fukuoka, M.12
  • 12
    • 0030912190 scopus 로고    scopus 로고
    • Revisions in the international system for staging lung cancer
    • Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997. (Pubitemid 27260107)
    • (1997) Chest , vol.111 , Issue.6 , pp. 1710-1717
    • Mountain, C.F.1
  • 13
    • 84958700139 scopus 로고    scopus 로고
    • A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small cell lung cancer (NSCLC) (final report)
    • Hasegawa Y, Takanashi S, Nakagawa H, Okudera K, Hayashi A, Morimoto T, Taima K and Okumura K: A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small cell lung cancer (NSCLC) (final report). Proc Am Soc Clin Oncol 23: #7333, 2005.
    • (2005) Proc Am Soc Clin Oncol , vol.23 , Issue.7333
    • Hasegawa, Y.1    Takanashi, S.2    Nakagawa, H.3    Okudera, K.4    Hayashi, A.5    Morimoto, T.6    Taima, K.7    Okumura, K.8
  • 15
    • 0002953816 scopus 로고
    • A computer program for estimation of creatine clearance from unstable serum creatine levels, age, sex and weight
    • Jellifie RW and Jelliffe SM: A computer program for estimation of creatine clearance from unstable serum creatine levels, age, sex and weight. Math Biosci 14: 17-24, 1972.
    • (1972) Math Biosci , vol.14 , pp. 17-24
    • Jellifie, R.W.1    Jelliffe, S.M.2
  • 16
    • 12344312699 scopus 로고    scopus 로고
    • Cancer Therapy Evaluation Program, Version 3.0, DCTD, NCI, NIH, DHHS
    • Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, 2003.
    • (2003) Common Terminology Criteria for Adverse Events
  • 17
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • DOI 10.1016/0197-2456(89)90015-9
    • Simon R: Optical two-stage designs for phase II clinical trial. Control Clin Trials 10: 1-10, 1989. (Pubitemid 19099520)
    • (1989) Controlled Clinical Trials , vol.10 , Issue.1 , pp. 1-10
    • Simon, R.1
  • 19
    • 33847276516 scopus 로고    scopus 로고
    • Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small cell lung cancer: Four-Arm Cooperative Study in Japan
    • Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y and Fukuoka M: Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18: 317-323, 2007.
    • (2007) Ann Oncol , vol.18 , pp. 317-323
    • Ohe, Y.1    Ohashi, Y.2    Kubota, K.3    Tamura, T.4    Nakagawa, K.5    Negoro, S.6    Nishiwaki, Y.7    Saijo, N.8    Ariyoshi, Y.9    Fukuoka, M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.